Novartis AG (NYSE: NVS) (“Novartis”) today announced the successful completion of the previously announced tender offer by its indirect wholly-owned subsidiary, Medusa Merger Corporation (“Purchaser”), for all of the outstanding shares of common stock, par value USD 0.001 per share, of The Medicines Company (NASDAQ: MDCO) (the “Company”) at a price of USD 85.00 per share, net to the seller in cash, without interest and subject to any tax withholding.
Read the full article: Novartis Completes Tender Offer for All Outstanding Shares of the Medicines Company //
Source: https://www.globenewswire.com/news-release/2020/01/06/1966217/0/en/Novartis-completes-tender-offer-for-all-outstanding-shares-of-The-Medicines-Company.html